Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John F Dillon

Showing results (121-130 of 176) with videos related to

Pageof 18
Sort By:
Journal of Hepatology|September 9, 2014
What is the impact of a country-wide scale-up in antiviral therapy on the characteristics and sustained viral response rates of patients treated for hepatitis C?Scott A McDonald, Hamish A Innes, Peter C Hayes, et al.
Journal of Hepatology|November 21, 2017
The risk of hepatocellular carcinoma in cirrhotic patients with hepatitis C and sustained viral response: Role of the treatment regimenHamish Innes, Stephen T Barclay, Peter C Hayes, et al.
Alimentary Pharmacology & Therapeutics|May 10, 2022
Reaching people receiving opioid agonist therapy at community pharmacies with hepatitis C virus: an international randomised controlled trialChristopher J Byrne, Andrew Radley, Sarah K Inglis, et al.
Frontline Gastroenterology|July 27, 2018
Development and validation of diagnostic triage criteria for liver disease from a minimum data set enabling the 'intelligent LFT' pathway for the automated assessment of deranged liver enzymesMichael Hugh Miller, Andrew Fraser, Gillian Leggett, et al.
Plos One|July 7, 2025
A protocol for the evaluation of the PneumoWave biosensor in supported accommodation settings: A study on feasibility and acceptability (RESCU-2)Basak Tas, Lewis Beer, Elizabeth Appiah-Kusi, et al.
The American Journal of Gastroenterology|August 16, 2022
Comparing Predicted Probability of Hepatocellular Carcinoma in Patients With Cirrhosis With the General Population: An Opportunity to Improve Risk Communication?Hamish Innes, Victoria Hamill, Scott A McDonald, et al.
Seminars in Liver Disease|July 10, 2018
The Micro-Elimination Approach to Eliminating Hepatitis C: Strategic and Operational ConsiderationsJeffrey V Lazarus, Kelly Safreed-Harmon, Mark R Thursz, et al.
The International Journal on Drug Policy|July 1, 2015
Expansion of HCV treatment access to people who have injected drugs through effective translation of research into public health policy: Scotland's experienceSharon J Hutchinson, John F Dillon, Ray Fox, et al.
JHEP Reports : Innovation in Hepatology|July 18, 2025
Prioritising viral hepatitis elimination to prevent hepatocellular carcinoma: A public health approach for effective preventive hepatologyDana Ivancovsky Wajcman, Aina Nicolàs, Camila A Picchio, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|September 13, 2024
Prevalence, trends, and distribution of hepatitis C virus among the general population in sub-Saharan Africa: A systematic review and meta-analysisGetahun Molla Kassa, Josephine G Walker, Tesfa Sewunet Alamneh, et al.
Pageof 18

Showing results (121-130 of 176) with videos related to

Sort By:
Pageof 18
Journal of Hepatology|September 9, 2014
What is the impact of a country-wide scale-up in antiviral therapy on the characteristics and sustained viral response rates of patients treated for hepatitis C?Scott A McDonald, Hamish A Innes, Peter C Hayes, et al.
Journal of Hepatology|November 21, 2017
The risk of hepatocellular carcinoma in cirrhotic patients with hepatitis C and sustained viral response: Role of the treatment regimenHamish Innes, Stephen T Barclay, Peter C Hayes, et al.
Alimentary Pharmacology & Therapeutics|May 10, 2022
Reaching people receiving opioid agonist therapy at community pharmacies with hepatitis C virus: an international randomised controlled trialChristopher J Byrne, Andrew Radley, Sarah K Inglis, et al.
Frontline Gastroenterology|July 27, 2018
Development and validation of diagnostic triage criteria for liver disease from a minimum data set enabling the 'intelligent LFT' pathway for the automated assessment of deranged liver enzymesMichael Hugh Miller, Andrew Fraser, Gillian Leggett, et al.
Plos One|July 7, 2025
A protocol for the evaluation of the PneumoWave biosensor in supported accommodation settings: A study on feasibility and acceptability (RESCU-2)Basak Tas, Lewis Beer, Elizabeth Appiah-Kusi, et al.
The American Journal of Gastroenterology|August 16, 2022
Comparing Predicted Probability of Hepatocellular Carcinoma in Patients With Cirrhosis With the General Population: An Opportunity to Improve Risk Communication?Hamish Innes, Victoria Hamill, Scott A McDonald, et al.
Seminars in Liver Disease|July 10, 2018
The Micro-Elimination Approach to Eliminating Hepatitis C: Strategic and Operational ConsiderationsJeffrey V Lazarus, Kelly Safreed-Harmon, Mark R Thursz, et al.
The International Journal on Drug Policy|July 1, 2015
Expansion of HCV treatment access to people who have injected drugs through effective translation of research into public health policy: Scotland's experienceSharon J Hutchinson, John F Dillon, Ray Fox, et al.
JHEP Reports : Innovation in Hepatology|July 18, 2025
Prioritising viral hepatitis elimination to prevent hepatocellular carcinoma: A public health approach for effective preventive hepatologyDana Ivancovsky Wajcman, Aina Nicolàs, Camila A Picchio, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|September 13, 2024
Prevalence, trends, and distribution of hepatitis C virus among the general population in sub-Saharan Africa: A systematic review and meta-analysisGetahun Molla Kassa, Josephine G Walker, Tesfa Sewunet Alamneh, et al.
Pageof 18